logo

For the Inventor, By the Inventor

Minneapolis, MN, United States of America

Xing-Ping Liu

USPTO Granted Patents = 18

Average Co-Inventor Count = 3.0

ph-index = 10

Forward Citations = 222(Granted Patents)


Company Filing History:

goldMedal16 out of 89 
 
Parker Hughes Institute
 patents
silverMedal2 out of 11 
 
Hughes Institute
 patents

Years Active: 2001-2006

Loading Chart...
18 patents (USPTO):Explore Patents
1. 7038049 - Haloanilino quinazolines and therapeutic use thereof (2006-05-02),
2. 6638939 - 6,7-dimethoxyquinazolines and therapeutic use thereof (2003-10-28),
3. 6592845 - Estrogens for treating ALS (2003-07-15),
4. 6552027 - Quinazolines for treating brain tumor (2003-04-22),
5. 6495556 - Dimethoxy quinazolines for treating diabetes (2002-12-17),
6. 6482816 - Organic arsenic compounds (2002-11-19),
7. 6482815 - Organic-arsenic compounds (2002-11-19),
8. 6469013 - Therapeutic compounds (2002-10-22),
9. 6410545 - Lipid lowering quinazoline dietary supplement composition (2002-06-25),
10. 6358962 - 6,7-Dimethoxyquinazolines and therapeutic use thereof (2002-03-19),
11. 6355645 - Lipid-lowering quinazoline derivative (2002-03-12),
12. 6334998 - Estrogens for treating ALS (2002-01-01),
13. 6316454 - 6,7-Dimethoxy-4-anilinoquinazolines (2001-11-13),
14. 6313129 - Therapeutic compounds (2001-11-06),
15. 6262053 - Melamine derivatives as potent anti-cancer agents (2001-07-17),

Certainly! Here is the article about inventor Xing-Ping Liu:

Title: The Inventor Profile: Xing-Ping Liu

Introduction:

Xing-Ping Liu, a prolific inventor based in Minneapolis, MN, has made significant contributions to the field of pharmaceuticals with numerous patents to his name. With a focus on developing innovative treatments for cancerous conditions and allergic reactions, Liu's work has garnered attention in the medical community.

Latest Patents:

Liu's latest patents showcase his expertise in the area of pharmaceutical research and development. His patents include inventions such as "Haloanilino quinazolines and therapeutic use thereof" and "6,7-dimethoxyquinazolines and therapeutic use thereof." These compounds offer promising solutions for the treatment of cancer and allergic reactions, highlighting Liu's dedication to advancing medical treatments.

Career Highlights:

Throughout his career, Xing-Ping Liu has been associated with esteemed institutions such as the Parker Hughes Institute and Hughes Institute. His work in these organizations has been instrumental in driving forward cutting-edge research and innovation in the field of pharmaceuticals. With a total of 18 patents to his name, Liu continues to push boundaries in the medical field.

Collaborations:

Liu has had the privilege of collaborating with renowned professionals in the industry, including Fatih M Uckun and Rama Krishna Narla. These partnerships have led to groundbreaking discoveries and advancements in the field of pharmaceuticals, showcasing Liu's ability to work effectively within team environments to achieve common goals.

Conclusion:

In conclusion, Xing-Ping Liu stands as a pioneering figure in the world of pharmaceutical innovations. His dedication to developing novel treatments for cancer and allergic reactions has not only earned him recognition but has also positively impacted the lives of many individuals. With a remarkable track record of patents and fruitful collaborations, Liu continues to inspire and drive progress in the field of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…